S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Versartis Initiates Global Phase 3 Study of VRS-317 in Children With Growth Hormone Deficiency|
|Versartis Announces Positive 12 Month Data for VRS-317 from Ongoing Extension Study (2015/1/5)|
|Versartis to Hold Conference Call to Discuss VRS-317 Clinical Update From Ongoing Extension Study|
|Versartis Schedules Conference Call to Discuss Plans for Phase 3 Trial for VRS-317 in Pediatric Growth Hormone Deficiency Patients|
|Versartis Reports Third Quarter 2014 Financial Results|
|Keith Lui Joins Versartis to Lead Global Marketing Efforts|
|Versartis to Present at the 2014 Credit Suisse Healthcare Conference|
|Versartis to Present at the 26th Annual Piper Jaffray Health Care Conference|
|Versartis Announces Proposed Offering of Common Stock|
|Versartis Announces Pricing of Follow-On Offering|
Click above to view more mutual fund data and stats for vr - Victory Resources Corp.